Sun Pharmaceutical Industries Ltd.

SUNPHARMA

₹1648.6

1.75% (28.4)

Market Cap

₹3,92,135 Cr.

P/E

37.81

Key Ratios

Edit Ratio's

Market cap

3.92 L Cr

37.81

Prom Holding

54.48 %

ROE (%)

15.13

ROCE (%)

21.10

Div Yield (%)

0.99

Sales

53,777 Cr

OPM (%)

28.48 %

Debt to Equity

0.03

Edit Ratio's

About

Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in… Read more

Low

1553

52W Range

High

1960

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Market Share

6.42 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.13 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.01 %

(as of Feb 20)

Historic

Anti-Malarial - Market Share

2.43 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

3.41 %

(as of Nov 21)

Historic

Blood Related - Market Share

6.88 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.19 %

(as of Nov 21)

Historic

Dermatology - Market Share

6.24 %

(as of Nov 21)

Historic

Endocrinology - Market Share

7.45 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

5.97 %

(as of Nov 21)

Historic

Gynecology - Market Share

22.70 %

(as of Nov 21)

Historic

Neurological - Market Share

13.47 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

2.98 %

(as of Nov 21)

Historic

Pain - Market Share

8.10 %

(as of Sep 24)

Historic

Pharmaceutical Sector - Market Share

3.63 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.75 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

3.62 %

(as of Nov 21)

Historic

Urology - Market Share

1.91 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
US DMF Filings (.)
Source
US DMF Approval (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Garlic Pearls

Revital

Volini

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Bharat Dynamics Ltd.
Laurus Labs Ltd.
Navin Fluorine International Ltd.
Aarti Industries Ltd.
Shaily Engineering Plastics Ltd.
Shakti Pumps (India) Ltd.
Borosil Renewables Ltd.
AGI Greenpac Ltd.
GMM Pfaudler Ltd.
Balaji Amines Ltd.
Aarti Drugs Ltd.
HLE Glascoat Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
TCPL Packaging Ltd.
Bliss GVS Pharma Ltd.
B.L. Kashyap and Sons Ltd.
Control Print Ltd.
Gulshan Polyols Ltd.
Bharat Parenterals Ltd.
Empire Industries Ltd.
Mold-Tek Technologies Ltd.
Inspirisys Solutions Ltd.
Zim Laboratories Ltd.
Zenotech Laboratories Ltd.
Jocil Ltd.
Hindusthan National Glass & Industries Ltd.

Showing 5 of 26

FAQs on Sun Pharmaceutical Industries Ltd. Business

What does Sun Pharma Inds. do?

Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, offering a wide range of high-quality and affordable products globally.

Who are the competitors of Sun Pharma Inds.?

Sun Pharma Inds. major competitors are Cipla, Torrent Pharma, Dr. Reddy's Lab, Mankind Pharma, Zydus Lifesciences, Lupin, Alkem Laboratories.
Market Cap of Sun Pharma Inds. is ₹3,88,752 Crs.
While the median market cap of its peers are ₹1,06,025 Crs.

Is Sun Pharma Inds. financially stable compared to its competitors?

Sun Pharma Inds. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Jul	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Dec
Investor Presentation	Jul Sep	Mar Jun Sep Nov Dec	Jan Mar Jun Sep Dec	Jan Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Mar Jun Sep	Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Sun Pharmaceutical Industries Ltd.

View the discussion on ValuePickr

Interview With Dilip Sanghvi, Managing Director - Sun Pharmaceutical Samir Mehta, Chairman - Torrent Pharma - Flame University

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

10 Yes

2 Neutral

5 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Price & Performance

Capex vs ROCE

ROE

Share price

Debt

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Working Capital

Sales Growth

Margin Stability

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Brands

Corporate Actions

Suppliers

FAQs on Sun Pharmaceutical Industries Ltd. Business

What does Sun Pharma Inds. do?

Who are the competitors of Sun Pharma Inds.?

Is Sun Pharma Inds. financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE